Jul 25, 2011Anavex Presents Data on Potential Dual Utility of ANAVEX 2-73 in Both Amyloid and Tau Pathology
Jul 16, 2011Preclinical Development of New Tetrahydrofuran Derivatives Targeting the Sigma-1 Chaperone Protein
Jul 15, 2011Anavex to Present at Alzheimer's Association International Conference on Alzheimer's Disease
Jul 6, 2011Anavex Rapidly Advances ANAVEX 2-73 for Alzheimer’s Disease, Phase I Clinical Trial Progressing Well